Fermenta Biotech has informed that the Board of Directors of the Company at its meeting held on February 12, 2020 has approved the unaudited financial results for the quarter and nine months ended December 31, 2019 (Standalone and Consolidated) as enclosed. Also enclosed Limited Review Report dated February 12, 2020 (along with the aforesaid Consolidated and Standalone unaudited financial Results) issued by the Company's Statutory Auditors, Deloitte Haskins & Sells LLP. The Board meeting commenced at 10:45 am and concluded at 12:55 pm.
The above information is a part of company’s filings submitted to BSE.
